California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

People with Type 1 diabetes lose insulin-producing beta cells due to an autoimmune reaction, forcing lifelong dependence on ...

California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make ...

California launches CalRx to sell half-price insulin and curb drug monopolies California to produce and sell state-branded ...

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

Gov. Gavin Newsom’s CalRx program will sell five-packs of insulin pens for $55 starting in January, a landmark step toward ...

Dr. Dasgupta says that detecting clues for diabetes can help you make changes, such as reducing sugar intake, before they ...

Scientists have uncovered a surprising new way the body can burn energy and stay warm. Deep inside fat tissue, they found a ...

Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.

NEW YORK, October 2 (Reuters) - Eli Lilly (LLY.N), opens new tab was asked to produce more insulin; Pfizer (PFE.N), opens new tab to produce more of its top-selling cancer drug Ibrance and its ...

China’s Ambassador to Nigeria, Yu Dunhai, disclosed plans by Chinese companies to establish a local insulin production facility in Nigeria. Yu said when completed, it would end Nigeria’s dependence on ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...